Anti-Nausea & Anti-Emetics Flashcards
what are the adverse effects of CB
euphoria/irritable
vertigo
sedation/drowsy
impaired cognition/memory
alteration of perception of reality
xerostomia
sympathomimetic (increase HR/BP)
appetite stimulation
what are the pharmakokinetics for serotonin receptor inhibitors
short 1/2-life
except PALONOsetron & sustained release form of GRANIsetron (SubQ)
==> long 1/2-life = effective for delayed CINV as single dose!
what NV medication is used for diabetic gastroparesis
metoclopramide
what drugs are used for CINV high-emetogenic regimen
3-drug regimen
- NK1 antagonist
- 5-HT3 antagonist
- corticosteroid (dexamethosome)
give prior to chemo (for acute NV) & 3 days after (for delayed NV)
what are the adverse effects and pharmakokinetics of substance P antagonists
Adverse effect: GI/CNS
Pharmacokinetics: NETUpitant/POLApitant have mod-major active metabolites - longer 1/2-life
mild to mod inhibition of few CYP450 enzymes *ALWAYS CHECK FOR DRUG INTERACTIONS*
what is the medication recommendation for CINV- minimal-emetogenic regimen
0 drug regimen!
no routine prophylaxis therapy recommended!
provide therapy for breakthrough NV or for anticipatory NV
what is the therapeutic use of H1 antagonists
idopathic, mild NV
PONV
NVP (dozylamine/b6)
motion sickness/vertigo (meclizine & cyclizine)
CINV (add-on)
RINV (add-on)
what is the suffix for 5-HT3 receptor antagonists?
list the drugs & mode of deliver
“-setron”
dolasetron (po/iv)
granisetron (1. cutaneous-24hr patch, 2. SubQ injection)
ondansetron (1. po/iv, 2. oral film)
palonosetron (1. iv, 2. po & iv combo w/ netupitant (po) & fosnetupitant (iv))
what are the drug recommendations for low-emetogenic regimen CINV
1-drug regimen (first 2 listed = MC)
- Corticosteroid (Dezamethasone) or
- 5-HT3 antagonist or
- Metoclopramide or
- Prochlorperazine
prior to chemo (for acute NV)
what are the therapeutic uses of CB
treatment resistant CINV (bc FDA scheduling)
could be add-on for CINV
appetite stimulation in anorexic pt due to severe dz
which N/V drugs have classic anticholinergic effects
H1 antagonists
D2 antagonists
muscarinic receptor blocker (obviously)
=drowsy, dry mouth, constipation, urinary retention, blurred vision
What are the medications changes made for CINV moderate-emetogenic regmin doesnt work
- increase to 3-drug regimen - add NK1 antagonist or. olanzapine
- CB in treatment resistant (after trying 3-drug regimen)
- therapy of breakthrough NV for all pts
- therapy for anticipatory NV
what is the difference btn acute, chronic and anticipatory NV for CINV
acute - <24 hr after chemo
chronic- >24 hr after chemo
anticipatory- occurs BEFORE chemo
*rmr proper therapy focus on prevention*
what is the most cost effective and clinically accepted treatment for NV
PREVENTION!
what are the therapeutic uses of D2 antagonists
idiopathic, mild NV
PONV (but 5-HT3 is 1st line)
NVP
gastroparesis/dysmotility (metoclopramide)
CINV & RINV (olanzapine used in combo w/ other CINV/RINV agents)
What receptors of the GI tract & heart contribute to the cause of N/V
mechanoreceptors
chemoreceptors
5-HT3 receptors
what is Scopolamine used for
motion sickness
end-of-life care for excessive secretions